Pathology is rapidly evolving as artificial intelligence, digital pathology, molecular diagnostics, and biomarker-driven testing become integral to modern healthcare.
Our latest case study surveyed 50 Key Opinion Leaders (KOLs) across the United States and Europe to understand the technologies, challenges, and opportunities shaping the future of diagnostic healthcare.
*Key insights include:
*
86% believe continued innovation is essential.
92% identify biomarker-driven diagnostics as critical for precision medicine.
88% expect significant growth in AI and digital pathology adoption.
82% believe AI will improve diagnostic accuracy and laboratory workflows.
90% are optimistic about the future of pathology and laboratory medicine.
Read the complete case study:
https://www.sperresearch.com/Case-Studies/future-of-pathology-and-laboratory-medicine-kol-survey
Top comments (0)